Literature DB >> 11068141

Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain.

R K Chan1, W W Vale, P E Sawchenko.   

Abstract

The corticotropin-releasing factor-binding protein is distinct from known corticotropin-releasing factor receptors, but can bind the peptide and neutralize its biological actions. Recent interest has centered about the therapeutic potential of "ligand inhibitors" of binding protein action, synthetic corticotropin-releasing factor fragments which are inactive at corticotropin-releasing factor receptors, but can displace the peptide from the binding protein, thereby increasing levels of free corticotropin-releasing factor. To identify sites of action of such ligands, the distribution of Fos expression seen following intracerebroventricular administration of rat/human corticotropin-releasing factor(6-33) (5-50 microg) was charted in relation to corticotropin-releasing factor-binding protein and receptor expression. It was expected that Fos induction would mimic aspects of the distribution of the two known corticotropin-releasing factor receptors, but the far greater correspondence was seen with that of the binding protein itself. This included neurons in the isocortex, the olfactory system, amygdala and a number of discrete brainstem cell groups; many Fos-immunoreactive neurons in each were found to co-express corticotropin-releasing factor-binding protein messenger RNA. Subsets of activated neurons co-expressed Type 1 corticotropin-releasing factor receptor messenger RNA, though these were largely limited to cell groups that also express the corticotropin-releasing factor-binding protein, and where binding protein immunoreactivity and Type 1 receptor transcripts were found to co-exist. Responsive neurons displaying Type 2 corticotropin-releasing factor receptor message were seen reliably only in the lateral septal nucleus. These findings support only a limited capacity of the ligand inhibitor to activate neurons bearing corticotropin-releasing factor receptors. The more pervasive activation seen among neurons that express the corticotropin-releasing factor-binding protein may be indicative of an unexpected role for this protein in signaling by corticotropin-releasing factor-related peptides.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11068141     DOI: 10.1016/s0306-4522(00)00322-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

Review 1.  Ventral tegmental glutamate: a role in stress-, cue-, and cocaine-induced reinstatement of cocaine-seeking.

Authors:  Roy A Wise
Journal:  Neuropharmacology       Date:  2008-06-13       Impact factor: 5.250

Review 2.  Distinct patterns of neuronal inputs and outputs of the juxtaparaventricular and suprafornical regions of the lateral hypothalamic area in the male rat.

Authors:  Joel D Hahn; Larry W Swanson
Journal:  Brain Res Rev       Date:  2010-02-17

3.  Systemic urocortin 2, but not urocortin 1 or stressin 1-A, suppresses feeding via CRF2 receptors without malaise and stress.

Authors:  E M Fekete; Y Zhao; A Szücs; V Sabino; P Cottone; J Rivier; W W Vale; G F Koob; E P Zorrilla
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

4.  Contrasting effects of pretraining, posttraining, and pretesting infusions of corticotropin-releasing factor into the lateral amygdala: attenuation of fear memory formation but facilitation of its expression.

Authors:  Koichi Isogawa; David E A Bush; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

Review 5.  Corticotropin-releasing hormone-binding protein and stress: from invertebrates to humans.

Authors:  Kyle D Ketchesin; Gwen S Stinnett; Audrey F Seasholtz
Journal:  Stress       Date:  2017-05-18       Impact factor: 3.493

6.  Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.

Authors:  Azusa Sekino; Hisayuki Ohata; Asuka Mano-Otagiri; Keiko Arai; Tamotsu Shibasaki
Journal:  Psychopharmacology (Berl)       Date:  2004-04-08       Impact factor: 4.530

Review 7.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons.

Authors:  Hui-Ling Wang; Marisela Morales
Journal:  J Comp Neurol       Date:  2008-07-20       Impact factor: 3.215

9.  Sequences, expression patterns and regulation of the corticotropin-releasing factor system in a teleost.

Authors:  Chun-Chun Chen; Russell D Fernald
Journal:  Gen Comp Endocrinol       Date:  2008-04-14       Impact factor: 2.822

10.  Deletion of corticotropin-releasing factor binding protein selectively impairs maternal, but not intermale aggression.

Authors:  S C Gammie; A F Seasholtz; S A Stevenson
Journal:  Neuroscience       Date:  2008-09-27       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.